Northern Trust
IDYA icon

Northern Trust’s IDEAYA Biosciences IDYA Stock Holding History

Northern Trust’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.5M Buy
734,121
+58,998
+9% +$1.98M ﹤0.01% 1551
2025
Q4 		$23.3M Sell
675,123
-34,738
-5% -$1.11M ﹤0.01% 1564
2025
Q3 		$19.3M Sell
709,861
-5,495
-0.8% -$133K ﹤0.01% 1712
2025
Q2 		$15M Sell
715,356
-38,173
-5% -$732K ﹤0.01% 1825
2025
Q1 		$12.3M Sell
753,529
-18,323
-2% -$390K ﹤0.01% 1918
2024
Q4 		$19.8M Buy
771,852
+484
+0.1% +$13.7K ﹤0.01% 1688
2024
Q3 		$24.4M Buy
771,368
+130,703
+20% +$4.96M ﹤0.01% 1497
2024
Q2 		$22.5M Sell
640,665
-2,803
-0.4% -$111K ﹤0.01% 1480
2024
Q1 		$28.2M Buy
643,468
+32,459
+5% +$1.4M ﹤0.01% 1358
2023
Q4 		$21.7M Buy
611,009
+49,641
+9% +$1.48M ﹤0.01% 1559
2023
Q3 		$15.1M Buy
561,368
+19,380
+4% +$491K ﹤0.01% 1732
2023
Q2 		$12.7M Buy
541,988
+137,485
+34% +$2.83M ﹤0.01% 1885
2023
Q1 		$5.55M Buy
404,503
+174
+0% +$2.9K ﹤0.01% 2398
2022
Q4 		$7.35M Buy
404,329
+83,821
+26% +$1.41M ﹤0.01% 2223
2022
Q3 		$4.78M Sell
320,508
-8,143
-2% -$106K ﹤0.01% 2513
2022
Q2 		$4.54M Buy
328,651
+26,082
+9% +$290K ﹤0.01% 2581
2022
Q1 		$3.39M Sell
302,569
-9,856
-3% -$145K ﹤0.01% 2812
2021
Q4 		$7.39M Buy
312,425
+3,681
+1% +$85.5K ﹤0.01% 2453
2021
Q3 		$7.87M Buy
308,744
+47,870
+18% +$1.12M ﹤0.01% 2448
2021
Q2 		$5.47M Buy
260,874
+90,729
+53% +$1.86M ﹤0.01% 2788
2021
Q1 		$4M Sell
170,145
-30,300
-15% -$585K ﹤0.01% 2881
2020
Q4 		$2.81M Buy
200,445
+29,943
+18% +$406K ﹤0.01% 3011
2020
Q3 		$2.14M Buy
170,502
+41,635
+32% +$516K ﹤0.01% 3032
2020
Q2 		$1.83M Buy
+128,867
New +$1.02M ﹤0.01% 3083

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Northern Trust's IDYA Position: Q1 2026 in Review

Northern Trust increased its IDEAYA Biosciences (IDYA) stake by 8.7% in Q1 2026, buying an estimated $1.98M and bringing the position to 734,121 shares worth $24.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1551.

Northern Trust first reported a position in IDYA in Q2 2020 and has held it in 24 quarters since. The position peaked at $28.2M in Q1 2024. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Northern Trust held 734,121 shares of IDEAYA Biosciences worth $24.5M as of Q1 2026.
  • Northern Trust bought 58,998 IDEAYA Biosciences shares in Q1 2026, an estimated $1.98M.
  • IDEAYA Biosciences made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #1551 holding.
  • Northern Trust first reported a position in IDEAYA Biosciences in Q2 2020 and has held it in 24 quarters since.
  • Northern Trust's IDEAYA Biosciences position peaked at $28.2M in Q1 2024.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.